TB-500 (Ac-LKKTETQ) and Thymosin Beta-4 Interaction

Compatible
Researched 90% confidence

TB-500 (Ac-LKKTETQ) and Thymosin Beta-4 have a compatible interaction with 90% confidence. TB-500 is the active fragment; combining may be redundant. Both compounds affect the blood vessels, so monitoring these systems is recommended.

Compound Profiles

TB-500 (Ac-LKKTETQ)

Thymosin Beta-4 Active Fragment | Healing Peptide

TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration.

Half-life: Not precisely established; effects persist longer than 24 hours Typical dose: 2-2.5mg per injection healing, longevity
vegf teratogenic
View full profile

Thymosin Beta-4

43-Amino Acid Regenerative Peptide | Tissue Repair & Healing

Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation..

Half-life: Dose-dependent; relatively short (exact values not established) Typical dose: 2-6mg per injection (varies by protocol and severity) healing, immune, longevity
View full profile

Combined Organ Load

Blood Vessels
low

Frequently Asked Questions

Can I take TB-500 (Ac-LKKTETQ) with Thymosin Beta-4?

Yes, TB-500 (Ac-LKKTETQ) and Thymosin Beta-4 can generally be taken together. TB-500 is the active fragment; combining may be redundant.

Is TB-500 (Ac-LKKTETQ) and Thymosin Beta-4 safe together?

Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.

What are the interactions between TB-500 (Ac-LKKTETQ) and Thymosin Beta-4?

TB-500 is the active fragment; combining may be redundant. This assessment has 90% confidence and is based on documented research data.

How should I time TB-500 (Ac-LKKTETQ) and Thymosin Beta-4?

TB-500 (Ac-LKKTETQ) has a half-life of Not precisely established; effects persist longer than 24 hours and Thymosin Beta-4 has a half-life of Dose-dependent; relatively short (exact values not established). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: TB-500 (Ac-LKKTETQ) vs Thymosin Beta-4

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.